47 results
8-K
EX-99.1
POAI
Predictive Oncology Inc
14 Nov 23
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
by validating the data package for these assets, making them ideal candidates for potential out-licensing.”
“We were also very pleased to announce, just
8-K
EX-10.1
POAI
Predictive Oncology Inc
20 Oct 22
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company Growth
8:31am
modifications to this benefits package that it deems appropriate from time to time. In your position as Chief Executive Officer, you will receive
DEFA14A
sgo6s6phky8 v3cz9s
20 Jul 21
Additional proxy soliciting materials
8:30am
8-K
EX-10.3
uxco5zaa8igvlmvl
23 Mar 21
Predictive Oncology Inc. Announces New CEO
8:30am
8-K
EX-1.1
8wgiaansdt4y
10 Oct 19
Predictive Oncology Inc. Announces Proposed Public Offering of Common Stock
4:45pm
8-K
EX-1.1
3176k0eld wjbk
2 Apr 19
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities
11:32am
425
EX-1.1
jsvx72
2 Apr 19
Business combination disclosure
11:30am
8-K
EX-1.1
s9k6lewv4
1 Mar 19
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities
3:02pm
425
EX-1.1
yi7nhr
1 Mar 19
Business combination disclosure
3:00pm
424B3
8s5975gmyika
6 Apr 16
Prospectus supplement
12:00am
424B4
dx5qib js5a
27 Aug 15
Prospectus supplement with pricing info
12:00am